Dirickx Bart
ActiveSummary
Dirickx Bart has been active since 2014 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €18,660 and a net result of €101,558. Equity has been stable since 2018 (±1.4% per year). Its solvency ranks better than 10% of 20,720 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Overview
Overview
Official details
Source: KBO- Status
- Active since 10-12-2014 Normal situation
- Activity
- General medical practice NACE 86210
- Establishment units
- 2.238.184.730 3960 Bree, since 19-12-2014
- 2.282.194.026 3960 Bree, since 01-11-2018
- Financial year end
- 31 December
- Peppol
- Reachable since 18-12-2024
Financial position
- Bankruptcy probabilitywithin 12 months
- < 0.1%
- Gross margin
- €163,839
- ▲ 5.3%
- Turnover
- ≈ €300,000
- estimated
- Profit
- €101,558
- ▲ 2.4%
- Equity
- €18,660
- ▼ 32.9%
- Total assets
- €346,673
- ▲ 2.9%
Score breakdownraises riskEquity €18,660 (5.4% of total assets)lowers riskSector: Human health activities (NACE 86)Size: total assets €346,673Figures for financial year 2025 (filed on 23-03-2026)Show the evidence
Checked score
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 11% of them on solvency, 39% on liquidity, 80% on profitability and 17% on growth.
The bankruptcy probability was computed on 04-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 7 accounts on average 49 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
Financials
Financials · financial year 2025, micro format
Annual accounts 2025 filed on 17-03-2026 PDF all 11 filings
Every figure per financial year
The operating result for 2025 is 3% higher than in 2024 and the highest since 2018. It is the fourth rise in a row, after the fall in 2021.
Turnover and EBIT margin are not published. The micro format does not require them. The turnover shown is an estimate from the gross margin.
Securities and guarantees
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Mortgages, amount registered | €322,102 | - | - | - | - |
| Carrying value of the mortgaged assets | €245,969 | - | - | - | - |
| Guarantees given for others' debts | €265,000 | - | - | - | - |
Source: notes to the 2021 to 2025 annual accounts (statement of debts and off-balance-sheet rights and commitments)
Investments
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Tangible fixed assets | €8,471 | €6,429 | €4,283 | €1,359 | €39,995 |
| Financial fixed assets | - | - | - | - | €0 |
| Depreciation and write-downs of the year | €60,055 | €23,038 | €23,859 | €22,722 | €27,212 |
Source: notes to the 2021 to 2025 annual accounts (statement of fixed assets)
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €64,732 | €58,680 | €58,513 | €60,055 | €23,038 | €23,859 | €22,722 | €27,212 | ▲ 19.8% |
| Other operating charges640/8 | - | - | - | €526 | €595 | €577 | €1,210 | €1,308 | ▲ 8.1% |
| Gross operating margin9900 | €107,711 | €130,947 | €139,968 | €114,745 | €106,947 | €124,803 | €155,650 | €163,839 | ▲ 5.3% |
| Operating profit (loss)9901 | €40,177 | €69,287 | €81,455 | €54,164 | €83,314 | €100,367 | €131,718 | €135,318 | ▲ 2.7% |
| Financial income75/76B | - | - | - | - | - | €2 | €10 | €1 | ▼ 94.0% |
| Recurring financial income75 | €0 | €0 | €0 | - | - | €2 | €10 | €1 | ▼ 94.0% |
| Financial charges65/66B | - | - | - | €6,915 | €6,114 | €5,702 | €5,209 | €5,085 | ▼ 2.4% |
| Recurring financial charges65 | €6,997 | €8,842 | €8,590 | €6,915 | €6,114 | €5,702 | €5,209 | €5,085 | ▼ 2.4% |
| Profit (loss) for the period before taxes9903 | €33,180 | €60,445 | €72,865 | €47,249 | €77,200 | €94,667 | €126,519 | €130,233 | ▲ 2.9% |
| Income taxes67/77 | €5,107 | €12,245 | €13,244 | €10,349 | €16,231 | €19,560 | €27,389 | €28,675 | ▲ 4.7% |
| Profit (loss) for the period9904 | €28,073 | €48,200 | €59,621 | €36,899 | €60,968 | €75,108 | €99,130 | €101,558 | ▲ 2.4% |
| Profit (loss) for the period to be appropriated9905 | €28,073 | €48,200 | €59,621 | €36,899 | €60,968 | €75,108 | €99,130 | €101,558 | ▲ 2.4% |
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Total assets20/58 | €603,535 | €451,406 | €414,277 | €340,525 | €333,841 | €321,252 | €337,009 | €346,673 | ▲ 2.9% |
| Fixed assets21/28 | €429,056 | €407,550 | €354,888 | €303,304 | €286,694 | €267,119 | €245,756 | €258,539 | ▲ 5.2% |
| Intangible fixed assets21 | €113,526 | €75,658 | €37,799 | - | - | - | - | - | - |
| Tangible fixed assets22/27 | €315,530 | €331,893 | €317,088 | €303,304 | €286,694 | €267,119 | €245,756 | €258,539 | ▲ 5.2% |
| Land and buildings22 | - | - | - | €294,579 | €275,580 | €260,591 | €241,163 | €221,736 | ▼ 8.1% |
| Plant, machinery and equipment23 | - | - | - | €4,403 | €7,513 | €3,648 | €2,432 | €779 | ▼ 68.0% |
| Furniture and vehicles24 | - | - | - | €4,321 | €3,601 | €2,881 | €2,160 | €36,025 | ▲ 17× |
| Current assets29/58 | €174,479 | €43,856 | €59,390 | €37,221 | €47,147 | €54,133 | €91,253 | €88,134 | ▼ 3.4% |
| Amounts receivable within one year40/41 | €18,219 | €8,404 | - | €1,651 | €769 | €440 | €1,669 | €973 | ▼ 41.7% |
| Trade receivables40 | - | - | - | - | - | - | €1,058 | €0 | ▼ 100% |
| Other amounts receivable41 | - | - | - | €1,651 | €769 | €440 | €611 | €973 | ▲ 59.1% |
| Cash at bank and in hand54/58 | €154,497 | €34,628 | €21,711 | €27,463 | €39,532 | €45,839 | €78,164 | €81,945 | ▲ 4.8% |
| Deferred charges and accrued income490/1 | - | - | - | €8,108 | €6,846 | €7,854 | €11,419 | €5,216 | ▼ 54.3% |
| Equity and liabilities | |||||||||
| Total equity and liabilities10/49 | €603,535 | €451,406 | €414,277 | €340,525 | €333,841 | €321,252 | €337,009 | €346,673 | ▲ 2.9% |
| Equity10/15 | €20,526 | €20,526 | €20,526 | €20,526 | €20,526 | €18,660 | €27,790 | €18,660 | ▼ 32.9% |
| Contributions10/11 | €18,660 | €18,660 | - | €18,660 | €18,660 | €18,660 | €18,660 | €18,660 | = |
| Reserves13 | €1,866 | €1,866 | €1,866 | €1,866 | €1,866 | €0 | €9,130 | €0 | ▼ 100% |
| Non-distributable reserves130/1 | - | - | - | €1,866 | - | - | - | - | - |
| Reserves not available under the articles1311 | - | - | - | €1,866 | - | - | - | - | - |
| Distributable reserves133 | - | - | - | - | €1,866 | €0 | €9,130 | €0 | ▼ 100% |
| Profit (loss) carried forward14 | - | - | - | - | - | €0 | €0 | €0 | - |
| Amounts payable17/49 | €583,009 | €430,880 | €393,751 | €319,999 | €313,315 | €302,592 | €309,219 | €328,013 | ▲ 6.1% |
| Amounts payable after more than one year17 | €379,541 | €328,659 | €276,797 | €247,920 | €223,076 | €209,793 | €196,199 | €189,937 | ▼ 3.2% |
| Financial debts170/4 | - | - | - | €247,920 | €223,076 | €209,793 | €196,199 | €189,937 | ▼ 3.2% |
| Amounts payable within one year42/48 | €203,468 | €102,221 | €116,955 | €72,079 | €90,239 | €92,799 | €105,915 | €137,557 | ▲ 29.9% |
| Current portion of amounts payable after more than one year42 | - | - | - | €28,877 | €24,844 | €13,283 | €13,593 | €23,831 | ▲ 75.3% |
| Trade debts44 | €2,282 | €1,195 | €1,006 | €1,882 | €2,667 | €0 | - | - | - |
| Suppliers440/4 | - | - | - | €1,882 | €2,667 | €0 | - | - | - |
| Taxes, remuneration and social security45 | - | - | - | €2,944 | €1,700 | €13,246 | €15,000 | €18,778 | ▲ 25.2% |
| Taxes450/3 | - | - | - | €2,944 | €1,700 | €13,246 | €15,000 | €18,778 | ▲ 25.2% |
| Other amounts payable47/48 | - | - | - | €38,375 | €61,028 | €66,270 | €77,322 | €94,948 | ▲ 22.8% |
| Accrued charges and deferred income492/3 | - | - | - | - | - | - | €7,104 | €519 | ▼ 92.7% |
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €28,073 | €48,200 | €59,621 | €36,899 | €60,968 | €75,108 | €99,130 | €101,558 | ▲ 2.4% |
| + Depreciation and write-downs630 | €64,732 | €58,680 | €58,513 | €60,055 | €23,038 | €23,859 | €22,722 | €27,212 | ▲ 19.8% |
| Operating cash flow (approximation) | €92,805 | €106,880 | €118,134 | €96,954 | €84,006 | €98,966 | €121,852 | €128,771 | ▲ 5.7% |
| Investment in fixed assets (approximation) | - | -€37,175 | -€5,851 | -€8,471 | -€6,429 | -€4,283 | -€1,359 | -€39,995 | ▼ 2,843% |
| Change in cash | - | -€119,870 | -€12,917 | €5,752 | €12,069 | €6,307 | €32,325 | €3,781 | ▼ 88.3% |
A Belgian filing has no cash-flow statement. These rows are therefore an approximation, derived from the income statement and the balance-sheet moves.
Historical observation
In July 2024, 1,325 companies had the same profile as Dirickx Bart has now. Two years later, 95.2% were still going and 1.4% had gone bankrupt.
- Micro
- 10 to 20 years old
- solvency under 10%
- a profit of 5% of the balance sheet or more
Another 0.2% stopped without a precise date, possibly only after those two years.
The bankruptcy probability of Dirickx Bart itself is lower: < 0.1% within 12 months. It rests on far more data about Dirickx Bart than the profile alone.
Test of the method
The method was tested on the 497,446 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 1,325 companies, not a prediction for Dirickx Bart. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Latest 10 of 11 filings with the National Bank
| Financial year | Type | Filed | Reference | Document |
|---|---|---|---|---|
| 31-12-2025 | micro format | 17-03-2026 | 2026-00059195 | |
| 31-12-2024 | micro format | 18-06-2025 | 2025-00153086 | |
| 31-12-2023 | micro format | 11-06-2024 | 2024-00120905 | |
| 31-12-2022 | micro format | 23-06-2023 | 2023-00161533 | |
| 31-12-2021 | micro format | 27-06-2022 | 2022-20104597 | |
| 31-12-2020 | micro format | 12-08-2021 | 2021-48500425 | |
| 31-12-2019 | micro format | 09-06-2020 | 2020-16200146 | |
| 31-12-2018 | micro format | 12-07-2019 | 2019-32200126 | |
| 31-12-2017 | micro format | 17-07-2018 | 2018-33300331 | |
| 31-12-2016 | micro format | 21-06-2017 | 2017-19400276 |
Board & ownership
Directors
Owners and capital
Capital transactions
- 22-11-2022 Converted to unavailable equity · €20,526
Mandate history
- Board
- mandate already running before its first mention
| Name | Functions and periods |
|---|---|
| DIRICKX Bart Celina Eduard |
|
Articles of association
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- At least 1 director
Articles of association, deed of 22-11-2022 (in Dutch)
Network & group
Companies at the same address
1 other companyConnections & network
1 connected companyThe connected companies are in the list below.
Timeline
Deeds, filings and financial milestones
22-11
Gazette deed
Company renamed from Dokter Dirickx Bart to Dirickx BartResignation: DIRICKX Bart Celina Eduard (sole director) · Reappointment: DIRICKX Bart Celina Eduard (director) · “De uitoefening van de geneeskunde met specialisatie huisarts door de arts-aandeelhouder,met inachtneming van…” (deed in Dutch)6 points ▸
- General meeting, 09-11-2022
- Name change, Dirickx Bart
- 186 shares
- Director resignation, DIRICKX Bart Celina Eduard (sole director)
- Director reappointment, DIRICKX Bart Celina Eduard (director (not named in the articles))
- Registered office clause, Hansweg 11, 3960 Bree
- The deed holds 6 more points.
Sources:Publications in the Belgian Official GazetteFilings with the National Bank
History
Company details
Register details
Identity
KBO recordRegistered office and establishments
Activities
NACEBEL 2025Codes under NACEBEL 2008
13 activities
- De uitoefening van de geneeskunde met specialisatie huisarts door de arts-aandeelhouder,met inachtneming van de regels van de medische deontologie.
- De aandeelhouder oefent zijn volledige medische activiteit uit in naam en voor rekening van de vennootschap.
- De professionele aansprakelijkheid van de arts-aandeelhouder is onbeperkt.
- Deze activiteiten worden uitgeoefend met eerbiediging van de deontologische en administratieve voorschriften,volgens de principes van de medische ethiek en de eisen van de wetenschappelijke discipline.Meer bepaald zal de vrije artsenkeuze in hoofde van de patiënt,de diagnostische en therapeutische vrijheid alsook het respect voor het medisch beroepsgeheim behouden blijven.
- De vennootschap waakt erover dat de onafhankelijkheid van de aandeelhouder in de uitoefening van zijn beroep gewaarborgd blijft en dat geen aanleiding ontstaat tot commerciële beoefening van de geneeskunde,tot directe of indirecte collusie,dichotomie of overconsumptie.
- Het inrichten van algemene diensten en een medisch secretariaat in het bijzonder,die nodig of nuttig zijn voor de uitoefening van voornoemde activiteiten;
- De aankoop,het huren,leasen en invoeren van alle medische apparatuur en begeleidende accommodaties,inclusief gebouwen en transportmiddelen,voor voornoemde activiteiten,kortom van een volledige materiële infrastructuur voor de praktijk van de arts-aandeelhouder;
- Het aanleggen van reserves,nodig tot het aanschaffen van alle dienstige apparatuur,gebouwen en transportmiddelen noodzakelijk en bevorderlijk voor het uitoefenen van alle bovenvermelde beroepsactiviteiten door de arts-aandeelhouder;
- De mogelijkheid scheppen om de aandeelhouder toe te laten zich verder te bekwamen in voormelde medische disciplines,dit teneinde een kwalitatief hoogstaande praktijkuitoefening mogelijk te maken.Bovendien kan de vennootschap informatie verstrekken en of onderricht geven,zonder dat dit de vorm van een aanvullende commerciële activiteit mag aannemen.
- De vennootschap mag samenwerken met alle ondernemingen die een gelijkaardig voorwerp nastreven,maar overeenkomsten die artsen niet mogen afsluiten met andere artsen of met derden,zullen evenmin door de vennootschap mogen afgesloten worden.Aldus zal de vennootschap geen deelnemingen mogen bezitten van een andere artsenvennootschap waarbinnen een medische activiteit wordt uitgeoefend.
- De vennootschap kan deelnemen in kostenassociaties of middelenvennootschappen van artsen,of lid zijn van een vereniging zonder winstgevend doel van artsen.
- De vennootschap mag als bijkomstig voorwerp,beleggen in roerende of onroerende goederen,mits dit een beheren is als een goede huisvader,en zonder dat dit op geen enkel ogenblik aanleiding mag geven tot het ontwikkelen van welke commerciële activiteit ook.Wanneer er meerdere aandeelhouders zijn,dienen de beslissingen in verband met het investeringsbeleid te gebeuren met unanimiteit van stemmen.
- De vennootschap zal in het algemeen alle burgerlijke,roerende of onroerende handelingen mogen verrichten in rechtstreeks verband met haar voorwerp of welke van die aard zouden zijn dat zij het bereiken ervan rechtstreeks,geheel of ten dele vergemakkelijken,dit alles rekening houdend met de medische deontologie ter zake.
Invoicing and payment
Financial year and general meeting
Accounts at the NBBSites & property
Buildings and parcels at the addresses
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 72402B0479/00H002 | Flanders | 2,412 m² | 1 · 300 m² | 0.6 m |
| 72004C1070/00D000 | Flanders | 181 m² | 1 · 55 m² | 30.8 m · 7 |